Higher-dose flu vaccine versus standard dose in child transplant patients
Part of Infections, Lungs & breathing clinical trials.
This trial compares a higher-dose flu vaccine to the standard dose in children who recently received a kidney, heart, and/or liver transplant. It aims to see which dose better protects children against influenza while checking for safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 3 to 17 years old
- Your child had a kidney, heart, and/or liver transplant between 1 month and under 24 months ago
- Your child’s transplant team expects you can stay in the study and contact you during the study (phone/email/text is OK)
- You can provide written permission for the study and your child can follow the vaccine study plan
- Your child has not had the current season’s flu vaccine since transplant (before joining)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a high-dose flu vaccine to the standard dose in lung transplant recipients. It aims to see if a higher dose gives better protection against the flu.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study looks at how the flu spreads from one person to another. Healthy volunteers will be exposed to flu from natural donors while staying in a facility, so researchers can learn more about transmission and help prevent future outbreaks.
This trial looks at an organized plan to give flu vaccines during hospital stays. It may help more inpatients get protected against influenza before they leave the hospital.
This trial tests how well the flu vaccine works in people with blood cancers like lymphoma, leukemia, or multiple myeloma. It aims to find the best vaccination strategy to protect you during treatment.
Hear when a new Immunization; Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.